SEC Form 4 research
| Issuer | Aspen Neuroscience, Inc. |
|---|---|
| Tickers | ASPE |
| Reporting owners | 27 |
| Officers and directors | 1 |
| Last public filing | 2026-11-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-02 | Thompson Peter A. | P | 1,000,000 | $15 | Not reported |
| 2026-11-04 | 2026-11-02 | ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC | P | 1,000,000 | $15 | Not reported |
| 2026-11-02 | 2026-11-02 | ARCH Venture Fund X Overage, L.P., ARCH Venture Fund X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X, LLC, Burow Kristina, CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT | P | 66,667 | $15 | Not reported |
| 2026-11-02 | 2026-11-02 | ARCH Venture Fund X Overage, L.P., ARCH Venture Fund X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X, LLC, Burow Kristina, CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT | P | 1,200,000 | $15 | Not reported |
| 2026-11-02 | 2026-11-02 | ARCH Venture Fund X Overage, L.P., ARCH Venture Fund X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X, LLC, Burow Kristina, CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT | P | 66,666 | $15 | Not reported |
| 2026-11-02 | 2026-11-02 | ARCH Venture Fund XIV, L.P., ARCH Venture Partners XIV, L.P., ARCH Venture Partners XIV, LLC, BERNS PAUL L | P | 1,200,000 | $15 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.